Cargando…

Perspective: Cell therapy, SARS‐CoV‐2, COVID‐19, and James Lind

Detalles Bibliográficos
Autor principal:	Gale, Robert P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Expert Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273049/ https://www.ncbi.nlm.nih.gov/pubmed/32838211 http://dx.doi.org/10.1002/acg2.88

Ejemplares similares

James Lind and Scurvy
por: Stockman, Ralph
Publicado: (1926)

James Lind and the prevention of scurvy
por: Wyatt, H. V.
Publicado: (1976)

James Lind, Founder of Nautical Medicine
Publicado: (1951)

James Lind and the cure of scurvy: an experimental approach.
por: Hughes, R E
Publicado: (1975)

The James Lind Alliance process approach: scoping review
por: Nygaard, Agnete, et al.
Publicado: (2019)

SARS-CoV-2 and Multi-Organ damage – What men's health specialists should know about the COVID-19 pathophysiology
por: Teixeira, Thiago A., et al.
Publicado: (2021)

Surveillance and control of SARS‐CoV‐2 in mustelids: An evolutionary perspective
por: Díaz, Adriana V., et al.
Publicado: (2021)

Role of the Pangolin in Origin of SARS-CoV-2: An Evolutionary Perspective
por: Gupta, Shishir K., et al.
Publicado: (2022)

Research Response to SARS-CoV-2/COVID-19
por: Burger, Charles D., et al.
Publicado: (2020)

Evolution of Clinical Research: A History Before and Beyond James Lind
por: Bhatt, Arun
Publicado: (2010)

Evolution of clinical research: A history before and beyond James Lind
por: Baron, Jeremy Hugh
Publicado: (2012)

Elbow conditions: research priorities setting in partnership with the James Lind Alliance
por: Singh, Harvinder Pal, et al.
Publicado: (2022)

Research priorities for pregnancy hypertension: a UK priority setting partnership with the James Lind Alliance
por: Ho, Alison, et al.
Publicado: (2020)

SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population
por: Vogl, Thomas, et al.
Publicado: (2021)

COVID-19 and sunlight: Impact on SARS-CoV-2 transmissibility, morbidity, and mortality
por: Sharun, Khan, et al.
Publicado: (2021)

Tackling treatment uncertainties together: the evolution of the James Lind Initiative, 2003–2013
por: Chalmers, Iain, et al.
Publicado: (2013)

Research priorities in pernicious anaemia: James Lind Alliance Priority Setting Partnership
por: Staley, Kristina, et al.
Publicado: (2022)

Superantigens and SARS-CoV-2
por: Hamdy, Adam, et al.
Publicado: (2022)

Research priorities in advanced heart failure: James Lind alliance priority setting partnership
por: Taylor, Clare J, et al.
Publicado: (2020)

COVID-19 control pitfalls and challenges and drivers of SARS-CoV-2 transmission in Zimbabwe
por: Murewanhema, Grant
Publicado: (2021)

Concise practice recommendations for the provision of andrological services and assisted reproductive technology for male infertility patients during the SARS-CoV-2 in Brazil
por: Hallak, Jorge, et al.
Publicado: (2020)

SARS-CoV-2-induced autophagy dysregulation may cause neuronal dysfunction in COVID-19
por: Lakshmana, Madepalli K.
Publicado: (2021)

SARS-CoV-2-Induced Amyloidgenesis: Not One, but Three Hypotheses for Cerebral COVID-19 Outcomes
por: Gonçalves, Carlos-Alberto, et al.
Publicado: (2022)

SARS-CoV-2 getting into the brain; neurological phenotype of COVID-19, and management by nano-biotechnology
por: Kujawska, Małgorzata, et al.
Publicado: (2022)

A persistent pneumothorax? 5-year follow-up after diagnosis of Swyer–James–MacLeod syndrome
por: Tufman, Amanda, et al.
Publicado: (2016)

Profile: James Davies
por: Armstrong, Neil
Publicado: (2014)

Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity
por: Burtscher, Johannes, et al.
Publicado: (2020)

Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines
por: Zhou, Weilin, et al.
Publicado: (2021)

Role of inactivated SARS-CoV-2 vaccine induced T cell responses in ameliorating COVID-19 severity
por: Huang, Hongming, et al.
Publicado: (2023)

Equitable distribution of SARS-CoV-2 tests
por: Garcia-Bereguiain, Miguel Angel, et al.
Publicado: (2022)

SARS-CoV-2 and Arthropods: A Review
por: Higgs, Stephen, et al.
Publicado: (2022)

SARS-CoV-2 S Glycoprotein Stabilization Strategies
por: Pedenko, Borys, et al.
Publicado: (2023)

Low-dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19
por: Hausdorff, William P., et al.
Publicado: (2021)

SARS-CoV-2 organising pneumonia: ‘Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?’
por: Kory, Pierre, et al.
Publicado: (2020)

Identifying acne treatment uncertainties via a James Lind Alliance Priority Setting Partnership
por: Layton, Alison, et al.
Publicado: (2015)

Rare musculoskeletal diseases in adults: a research priority setting partnership with the James Lind Alliance
por: Mickute, Gerda, et al.
Publicado: (2020)

UK Research Priorities for Electronic Cigarettes: A James Lind Alliance Priority Setting Partnership
por: Hunter, Abby, et al.
Publicado: (2020)

A patient–clinician James Lind Alliance partnership to identify research priorities for hyperemesis gravidarum
por: Dean, Caitlin R, et al.
Publicado: (2021)

Approaches and Challenges in SARS-CoV-2 Vaccine Development
por: Dagotto, Gabriel, et al.
Publicado: (2020)

SARS-CoV-2 Vaccines in Patients With Multiple Myeloma
por: Gavriatopoulou, Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tahetrsr81mu66mmvdusod5d5b